financetom
KEQU
financetom
/
Consumer Discretionary
/
KEQU
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Kewaunee Scientific CorporationKEQU
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.

The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.

It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Latest News >
Canada's Scotiabank misses profit estimates on higher taxes, expenses
Canada's Scotiabank misses profit estimates on higher taxes, expenses
Dec 3, 2024
(Reuters) - Bank of Nova Scotia missed analysts' estimates for quarterly profit on Tuesday, hurt by higher taxes and elevated expenses related to compensation and technology. Adjusted profit rose 29% to C$2.12 billion ($1.51 billion). On a per share basis, the lender earned C$1.57, compared with analysts' expectations of C$1.60 per share, according to LSEG data. The quarter included impairment...
BMO Comments on Canada's
BMO Comments on Canada's "Sore" GDP per Capita Growth
Dec 3, 2024
07:49 AM EST, 12/03/2024 (MT Newswires) -- Despite the positivity brought on by upward revisions to Canada's real gross domestic product, one sore spot remains: growth lags the still-strong population surge, noted Bank of Montreal (BMO). In fact, real GDP per capita has been declining for six straight quarters to Q3, which ties the early 1980s for the longest such...
Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept
Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept
Dec 3, 2024
07:52 AM EST, 12/03/2024 (MT Newswires) -- Keros Therapeutics ( KROS ) said Tuesday it has agreed to provide Takeda Pharmaceutical ( TAK ) with a global commercial license for elritercept, as well as to collaborate on the drug candidate's development. Keros said it expects to receive an upfront payment of $200 million, with milestone payments that could reach up...
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation
Dec 3, 2024
07:55 AM EST, 12/03/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday the US Food and Drug Administration has granted breakthrough therapy designation to sacituzumab tirumotecan, a treatment for certain times of non-small cell lung cancer. The designation is based on data from the phase 2 expansion group of a phase 1/2 study, as well as data from two...
Copyright 2023-2025 - www.financetom.com All Rights Reserved